Green Cross Holdings Preference Shares (005257) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Green Cross Holdings Preference Shares (005257) has a cash flow conversion efficiency ratio of -0.014x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-26.23 Billion ≈ $-17.78 Million USD) by net assets (₩1.86 Trillion ≈ $1.26 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Green Cross Holdings Preference Shares - Cash Flow Conversion Efficiency Trend (2013–2024)
This chart illustrates how Green Cross Holdings Preference Shares's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 005257 liabilities breakdown for a breakdown of total debt and financial obligations.
Green Cross Holdings Preference Shares Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Green Cross Holdings Preference Shares ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
VivoSim Labs, Inc.
NASDAQ:VIVS
|
-0.337x |
|
Magnetite Mines Ltd
AU:MGT
|
-0.030x |
|
NEWLOX GOLD VENTURES
F:NGO
|
N/A |
|
Abacus Mining and Exploration Corp
V:AME
|
0.003x |
|
International Biotechnology Trust plc
LSE:IBT
|
0.126x |
|
AltynGold plc
LSE:ALTN
|
0.201x |
|
Pearl Polymers Limited
NSE:PEARLPOLY
|
-0.101x |
|
Visionstate Corp
V:VIS
|
0.511x |
Annual Cash Flow Conversion Efficiency for Green Cross Holdings Preference Shares (2013–2024)
The table below shows the annual cash flow conversion efficiency of Green Cross Holdings Preference Shares from 2013 to 2024. For the full company profile with market capitalisation and key ratios, see Green Cross Holdings Preference Shares stock valuation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | ₩1.85 Trillion ≈ $1.26 Billion |
₩-89.95 Billion ≈ $-60.96 Million |
-0.049x | -130.42% |
| 2023-12-31 | ₩1.88 Trillion ≈ $1.28 Billion |
₩-39.65 Billion ≈ $-26.87 Million |
-0.021x | -142.67% |
| 2022-12-31 | ₩1.97 Trillion ≈ $1.33 Billion |
₩97.16 Billion ≈ $65.84 Million |
0.049x | -9.05% |
| 2021-12-31 | ₩1.91 Trillion ≈ $1.29 Billion |
₩103.77 Billion ≈ $70.32 Million |
0.054x | +154.07% |
| 2020-12-31 | ₩1.67 Trillion ≈ $1.13 Billion |
₩35.77 Billion ≈ $24.24 Million |
0.021x | +320.95% |
| 2019-12-31 | ₩1.51 Trillion ≈ $1.02 Billion |
₩7.65 Billion ≈ $5.18 Million |
0.005x | -80.40% |
| 2018-12-31 | ₩1.45 Trillion ≈ $984.76 Million |
₩37.64 Billion ≈ $25.51 Million |
0.026x | -74.19% |
| 2017-12-31 | ₩1.44 Trillion ≈ $975.64 Million |
₩144.48 Billion ≈ $97.91 Million |
0.100x | +17256.99% |
| 2016-12-31 | ₩1.38 Trillion ≈ $933.18 Million |
₩-805.47 Million ≈ $-545.86K |
-0.001x | -110.87% |
| 2015-12-31 | ₩1.31 Trillion ≈ $885.99 Million |
₩7.04 Billion ≈ $4.77 Million |
0.005x | -88.35% |
| 2014-12-31 | ₩1.18 Trillion ≈ $800.39 Million |
₩54.54 Billion ≈ $36.96 Million |
0.046x | +189.06% |
| 2013-12-31 | ₩1.10 Trillion ≈ $745.23 Million |
₩17.57 Billion ≈ $11.91 Million |
0.016x | -- |
About Green Cross Holdings Preference Shares
Green Cross Holdings Corporation operates as a biotechnology company. The company provides prescription drugs and over the counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pert… Read more